Recent Headlines
Within Generic Drugs
Tabula Rasa HealthCare CEO Calvin H. Knowlton Named Technology CEO of the Year
Tabula Rasa HealthCare Chairman and CEO, Calvin H. Knowlton, received the 2016 PACT Enterprise Award for Technology CEO of the Year at a gala event in Philadelphia, May 12. While accepting the award, Knowlton stated, "TRHC results include enhanced medication-related outcomes and greater operational efficiency. The work we are doing in medication informatics, personalized medication management, and compliance/assurance is exciting and, we believe, game changing." - June 03, 2016 - Tabula Rasa HealthCare
ValueCentric’s Training Conference, Focus 2016, Sells-Out in Record Time
ValueCentric, the leader in healthcare channel intelligence, today announced their annual user-training conference, being held in Princeton, NJ May 24th and 25th, has sold out. Anticipation for this event has accelerated with the company’s expanded data service offerings, a significant... - May 20, 2016 - ValueCentric
NJHA Brings Medication Risk Mitigation Services to New Jersey Hospitals Through Strategic Alliance with Tabula Rasa HealthCare
New Jersey Hospital Association and Tabula Rasa HealthCare (TRHC) have entered into a 3-year agreement to offer TRHC's proprietary Medication Risk Mitigation™ products and services to NJHA’s nearly 400 member healthcare organizations. - May 02, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare Names Kristen Propp Creative Director; Healthcare Technology Company Expands Marketing Heft with New Hire
Tabula Rasa HealthCare, Inc. (TRHC) President Orsula V. Knowlton announced graphic designer, Kristen Propp, has joined the healthcare technology company as Creative Director. TRHC is a leader in providing patient-specific, data-driven technology and solutions for health care organizations. - May 02, 2016 - Tabula Rasa HealthCare
ValueCentric’s Order Management Module Becomes Choice Solution for Top Pharma Manufacturers
ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for... - April 22, 2016 - ValueCentric
ValueCentric Expands Specialty Data Quality and Performance Measurement Reporting Capabilities
Dashboards and reports are now available to Specialty manufacturer clients through the ValueTrak Platform. - April 07, 2016 - ValueCentric
Global Medical Solutions to Sell China Operations to Yantai Dongcheng Biochemicals
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
Tabula Rasa HealthCare CIO Receives 2016 Executive Management Award
Tabula Rasa HealthCare CIO Joseph J. Filippoli was honored by SmartCEO Magazine with the 2016 Executive Management Award at a gala celebration March 8. The award recognizes the "leadership and accomplishments of Philadelphia's management all-stars. Winners are recognized for their creative management vision, leadership philosophy, innovative strategy and undeniable work ethic." - March 11, 2016 - Tabula Rasa HealthCare
Tabula Rasa Healthcare Pharmacy Simulation Software Tested by Schools of Pharmacy
Medication treatment is the most common medical intervention. Its imprecise use contributes to an estimated 45-50 million adverse drug events annually. Tabula Rasa's suite of software solutions provide prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to better manage the medication-related needs of patients. NiaRx provides electronic health record training and patient-case simulation for pharmacy students, the future of tomorrow's caregiving team. - February 15, 2016 - Tabula Rasa HealthCare
Coalition Forms to Study Medication Risk in Workforce Populations
Tabula Rasa HealthCare and The Greater Philadelphia Business Coalition on Health have partnered to examine the extent of medication risk in a diverse workforce population and the opportunities to mitigate that risk for the benefit of improving the health and welfare of employees and reducing unnecessary health care costs. - February 01, 2016 - Tabula Rasa HealthCare
SPIMACO CFO Ranked 2nd in a Middle East and North Africa Award
The 9th Annual CFO Strategies Forum recognized Mr. Fahad Al-Shammari, CFO of Saudi Pharmaceutical Industries and Medical Appliances Corporations (SPIMACO Addwaeih) for achieving the 2nd ranking in (Revolutionary CFO of the Year Award) during the MENA CFO Awards Ceremony held in Sofitel The Palm... - October 30, 2015 - SPIMACO
Tabula Rasa HealthCare Responds to CMS Announcement of Part D Enhanced Medication Therapy Managment Model
Under the CMS Enhanced MTM Model, the personalized MTM services offered by Tabula Rasa HealthCare are now eligible for reimbursement by CMS, and for additional performance-based payments. TRHC's Medication Risk Mitigation Matrix(TM) has proven to reduce adverse drug reactions. - October 29, 2015 - Tabula Rasa HealthCare
Tabula Rasa HealthCare CEO Named 2015 Health Care Innovator of the Year
Calvin H. Knowlton, Chairman and CEO, Tabula Rasa HealthCare, Inc. has been named Individual Health Care Innovator of the Year by the Philadelphia Business Journal. Knowlton is being recognized for his innovation in medication risk mitigation and personalized medicine. - October 20, 2015 - Tabula Rasa HealthCare
Oak Street Health and Tabula Rasa Healthcare Aim to Improve Patient Outcomes Through Optimization of Medication Regimens
Program's goal is to improve the safety of patient medication regimens and patient outcomes using Tabula Rasa's novel and proprietary MRM technolgy platform in tandem with the automated, robotic dispensary of TRHC's CareKinesis Pharmacy. - October 15, 2015 - Tabula Rasa HealthCare
KinderPharm LLC Acquires Clinical Pharmacology and Pharmacometric Research and Development Company
KinderPharm LLC., announced that it has acquired PKPD Bioscience, Inc., a clinical pharmacology and pharmacometric research and development company. The purchase will strengthen the capabilities of KinderPharm LLC to provide pediatric PK/PD modeling and simulation as well as Pop PK and sparse sampling. - September 01, 2015 - KinderPharm LLC
Ambu Partners with ValueCentric in Data Enhancement Initiative
Ambu chooses ValueCentric for their expertise in data cleansing and enhanced Master Data Management services. - August 27, 2015 - ValueCentric
KinderPharm Raises $1 Million to Further Advance Pediatric Drug Development
KinderPharm, a full-service contract research organization (CRO) dedicated exclusively to pediatric drug development, has raised $1 million from a Series A comprised of individuals, companies and angel investors. The $1 million investment will be used to further advance the clinical development of new medicines for children. - August 13, 2015 - KinderPharm LLC
ValueCentric Announces Advanced Service Level Monitoring Module
The module is part of a series of solution-oriented modules designed to provide users with one-click solutions to common problems. - July 15, 2015 - ValueCentric
GenToX is Now Offering Inherited Cancer Testing
Industry Leader in Pharmacogenomics is now offering inherited cancer screenings for patients to enhance their personalized medical testing services. - July 10, 2015 - GenToX
Tabula Rasa HealthCare Receives Top Innovator Company Award
Tabula Rasa HealthCare is recognized for its "innovative solutions that are making an impact on cost, quality, and access in health care." TRHC develops offerings for the ever-growing segment of the healthcare system that is "at risk," providing tools and services to better manage risk. - June 05, 2015 - Tabula Rasa HealthCare
Linking API Producers to API Customers - Connectivity Matters
The API Sourcing Database is a new Database to find producers of Active Pharmaceutical Ingredients including up to date quality information about the API. - June 02, 2015 - API Sourcing
ValueCentricIQ Unveils Innovative Mobile App
The app delivers comprehensive insights, industry trends, and benchmarking tools to the Pharmaceutical IndustryVCIQ Industry Benchmark app is now available on iOS, Android, and Desktop devices - May 13, 2015 - ValueCentric
More Philadelphia Area Hospitals Signing Up for GenToX Pharmacogenomic Testing
Local genetic testing company is experiencing rapid growth with support from the area’s leading medical professionals in joint efforts to bring personalized medical care to patients. - April 23, 2015 - GenToX
GenToX Nominated for Buzz of BIO Award for the Technology of Tomorrow Category
The Award is hosted by Biotechnology Industry Organization at the 2015 BIO International Convention. - April 18, 2015 - GenToX
ValueCentric Launches Expansion of Channel Data Visualizations with ValueTrak 7.0
Includes anticipated charting and analytic enhancements for pharmaceutical manufacturers. - March 11, 2015 - ValueCentric
Local Pharmacy Wants to Warm Those Less Fortunate
Country Village Chemists of Huntington Asks the Public to Support Their Annual Winter Coat Drive. - February 06, 2015 - North Country Drugs
Boston Healthcare Appoints Andreas H. Sander as Vice President and Managing Director of Boston Healthcare International GmbH
Boston Healthcare today announced the appointment of Andreas Sander as Vice President and Managing Director for Boston Healthcare International GmbH, leading the European team and the firm’s activities in Germany and Europe out of Boston Healthcare’s Berlin office. Mr. Sander brings... - January 21, 2015 - Boston Healthcare
Experimentica Ltd. Licenses Akimba Mouse Model for Diabetic Retinopathy from Lions Eye Institute, Australia
The Lions Eye Institute (LEI) and Experimentica Ltd., a global ophthalmic contract research organization (CRO) announced today that they have entered into an exclusive license agreement for the Akimba mouse model for diabetic retinopathy for contract research. The license agreement was facilitated by Bio-Link Australia, a life sciences commercialisation company. - December 20, 2014 - Experimentica Ltd
Clinical and Economic Impact of Next-Generation Sequencing Examined During Boston Healthcare’s Multi-Stakeholder Symposium
Boston Healthcare Associates, Inc. (BHA) and Cambridge Healthtech Institute (CHI) held an engaging, multi-stakeholder symposium surrounding the unique challenges and opportunities with the use of next-generation sequencing (NGS) in oncology care. Entitled, “Capturing the Value of... - December 12, 2014 - Boston Healthcare
Experimentica Ltd Announces a Strategic Partnership with the Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland
Experimentica Ltd., a Finland-based ophthalmic CRO, announces a strategic partnership with The Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland. SILK is a research network composed of research units engaged in basic and clinical eye and vision research. Dr. Giedrius... - November 19, 2014 - Experimentica Ltd
Summit Biosciences Announces Successful FDA Preapproval Inspection for Manufacturing of Nasal Spray Drug Product
Summit Biosciences Inc., a specialty pharmaceutical company, is pleased to announce that the manufacturing facility in Lexington, Kentucky has successfully passed its first preapproval inspection by the Food and Drug Administration (FDA). The inspection for a new nasal spray drug product, which... - March 28, 2014 - Summit Biosciences Inc.
NeoStrata Canada Struts Runway-Ready Skin at World MasterCard Fashion Week
NeoStrata Canada teams up with high fashion as the Official Skin Care and Anti-Aging Treatments Sponsor of World MasterCard® Fashion Week (WMCFW) in Toronto, running from March 17 to 21. WMCFW attendees and beauty editors can visit the NeoStrata booth on site or access content, tips and... - March 15, 2014 - Sanofi Canada
SFL Experts to Present and Chair Sessions at the 2014 DIA Annual Euromeeting in Vienna
SFL experts will present on EU medical device/IVD law, public & regulatory affairs synergies and transparency of payments to the healthcare sector at 2014 DIA Annual EuroMeeting. - February 12, 2014 - SFL Regulatory Affairs & Scientific Communication Ltd
EightSpokes Announces the Launch of Their Online Presence
EightSpokes, creators of Enlighten, a SaaS-based commercial excellence platform designed with life science companies in mind, announces the launch of their online presence, EightSpokes.com. The website highlights the “Noble Eightfold Path” that inspired the company’s approach to make work more rewarding. Enlighten adopts proven social collaboration technologies and ideas from industry leaders to put teams and team members at the center of every project’s successful execution. - January 29, 2014 - EightSpokes
American Regent, Inc. Takes Center Stage on The Balancing Act® Airing on Lifetime Talkshow
Make sure to tune in to The Balancing Act on December 11th and 18th at 7:00 am (ET/PT) as Blood specialist Dr. Lawrence Tim Goodnough, blood disease expert and Lynell D'Sylva, BSN, RN from American Regent explain what IDA is and introduce their innovative treatment option. - December 10, 2013 - American Regent, Inc.
SFL Managing Director Provides Further Update Regarding Revision of EU Medtech Legislation
SFL’s Managing Director, Shayesteh Fürst-Ladani will be giving presentations at two upcoming Swiss life science events on revision of EU Medtech legislation. - November 21, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL’s Managing Director to Give Presentation at Informa’s 8th Annual Drug Device Combination Products Event in Berlin
SFL’s Managing Director provides regulatory insight into Drug Device Combination Products in Europe. - November 13, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
The Changing Environment for Pharma and Medtech Companies in Europe
SFL Regulatory Affairs Consulting Ltd. (SFL) is pleased to be strengthening its activities in the UK and will be holding an inaugural and networking event in London on 8 October 2013. - September 30, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL’s Managing Director Invited to Share Expertise at “Pharma Meets Medtech” Event
SFL's Managing Director offers insights for better pharm and medtech collaboration - September 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL Appoints Advisory Board
SFL announces details of its Advisory Board. - March 22, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL Experts to Present and Chair Sessions at the 2013 DIA Annual EuroMeeting
SFL team showcase expertise in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications at DIA EuroMeeting in Amsterdam. - March 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
GenScript Upgrade Free Bioinformatics Tools
GenScript provides a comprehensive range of online bioinformatics tools for Molecular Biology, Peptide, and Protein Researchers，as well as many other common bioinformatics tools. - February 23, 2013 - GenScript USA Inc.
Greenwerkz Releases R4 Ultra-High CBD, Non-Psychoactive Strain as "Open Source"
Greenwerkz' high CBD/low THC strain genetics to become available to patients and medical marijuana centers (MMCs) in Colorado, free of charge. - February 14, 2013 - Greenwerkz
SFL’s Managing Director Invited to Speak at MEDTEC Europe Event in Stuttgart, Germany
SFL is pleased to announce that Shayesteh Fürst-Ladani, SFL’s Managing Director, has been invited to give a presentation on the classification and regulation of drug/device combinations at the MEDTEC Europe event to be held in Stuttgart, Germany from 26 to 28 February 2013. - February 13, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
GenScript Launches eBlot® Protein Transfer System
GenScript USA Incorporation has launched the eBlot® Protein Transfer System, a semi-dry electric blotter for transferring proteins from mini polyacrylamide gels onto membranes in 7 to 10 minutes, expanding its bench-top tool offerings for protein analysis. This system simplifies the process further by including a complete line of accessories, eliminating the need for additional buffers. - February 07, 2013 - GenScript USA Inc.
GenScript Launches New PolyExpress Package
With the completion of an extensive new animal facility and validation of ground-breaking new immunization protocols, GenScript is able to offer this new antibody package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods. - February 03, 2013 - GenScript USA Inc.
ProteinSignal - A New Brand of GenScript, Focused on Protein Research
ProteinSignal will serve as a pioneering developer and supplier of high performance protein research products covering the entire protein analysis workflow. Their offerings include cytokines and growth factors, protein purification resins, precast PAGE gels, protein standards, gel staining systems, anti-tag antibodies, western blot detection, ELISA kits and endotoxin detection and removal kits. - January 27, 2013 - GenScript USA Inc.
2012 - An Award-Winning Year for SFL
This year, SFL’s multifunctional expertise has been independently recognised through two important business awards. In July, Shayesteh Fürst-Ladani, Managing Director of the company, received the Open University Business School’s Alumni Award Outstanding Contribution to an... - December 19, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL Selected as Finalist in the British-Swiss Business Awards
SFL Regulatory Affairs & Scientific Communication Ltd (SFL) is proud to announce that the company has been selected as a finalist in the second annual British-Swiss Business Awards. - October 13, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL’s Managing Director Invited to Speak at World Medtech Forum
Shayesteh Fürst-Ladani, Managing Director of the SFL will speak on European Day at the World Medtech Forum in Lucerne, Switzerland. - September 22, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd